Suppr超能文献

常规固定移位的锁骨中段骨折不具有成本效益:一项随机对照试验的成本分析。

Routine fixation of displaced midshaft clavicle fractures is not cost-effective: a cost analysis from a randomized controlled trial.

机构信息

Department of Orthopaedic Surgery, University of Edinburgh, Edinburgh, UK.

出版信息

Bone Joint J. 2019 Aug;101-B(8):995-1001. doi: 10.1302/0301-620X.101B8.BJJ-2018-1253.R2.

Abstract

AIMS

The primary aim of this study was to establish the cost-effectiveness of the early fixation of displaced midshaft clavicle fractures.

PATIENTS AND METHODS

A cost analysis was conducted within a randomized controlled trial comparing conservative management (n = 92) early plate fixation (n = 86) of displaced midshaft clavicular fractures. The incremental cost-effectiveness ratio (ICER) was used to express the cost per quality-adjusted life-year (QALY). The Six-Dimension Short-Form Health Survey (SF-6D) score was used as the preference-based health index to calculate the cost per QALY at 12 months after the injury.

RESULTS

The mean 12-month SF-6D was 0.9522 (95% confidence interval (CI) 0.9355 to 0.9689) following conservative management and 0.9607 (95% CI 0.9447 to 0.9767) following fixation, giving an advantage for fixation of 0.0085, which was not statistically significant (p = 0.46). The mean cost per patient was £1322.69 for conservative management and £5405.32 for early fixation. This gave an ICER of £480 309.41 per QALY. For a threshold of £20 000 per QALY, the benefit of fixation would need to be present for 24 years to be cost-effective compared with conservative treatment. Linear regression analysis identified nonunion as the only factor to adversely influence the SF-6D at 12 months (p < 0.001).

CONCLUSION

Routine plate fixation of displaced midshaft clavicular fractures is not cost-effective. Nonunion following conservative management has an increased morbidity with comparable expense to early fixation. This may suggest that a targeted approach of fixation in patients who are at higher risk of nonunion would be more cost-effective than the routine fixation of all displaced fractures. Cite this article: 2019;101-B:995-1001.

摘要

目的

本研究的主要目的是确定移位锁骨中段骨折早期固定的成本效益。

患者和方法

在一项比较保守治疗(n=92)与早期钢板固定(n=86)的随机对照试验中进行成本分析。采用增量成本效益比(ICER)表示每质量调整生命年(QALY)的成本。采用六维度简明健康调查量表(SF-6D)评分作为偏好健康指数,计算损伤后 12 个月时每 QALY 的成本。

结果

保守治疗组 12 个月时平均 SF-6D 为 0.9522(95%置信区间[CI]0.9355 至 0.9689),固定组为 0.9607(95%CI0.9447 至 0.9767),固定组具有 0.0085 的优势,但无统计学意义(p=0.46)。保守治疗组患者平均每人费用为 1322.69 英镑,早期固定组为 5405.32 英镑。这给出了每 QALY 480309.41 英镑的 ICER。对于每 QALY20000 英镑的阈值,与保守治疗相比,固定的益处需要存在 24 年才能具有成本效益。线性回归分析发现,12 个月时,骨折不愈合是唯一对 SF-6D 产生不利影响的因素(p<0.001)。

结论

常规钢板固定移位锁骨中段骨折不具有成本效益。保守治疗后骨折不愈合会增加发病率,费用与早期固定相当。这可能表明,对骨折不愈合风险较高的患者进行固定的靶向治疗可能比常规固定所有移位骨折更具成本效益。

引用本文

2019;101-B:995-1001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验